杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/12/30 | 1,414 | 1,444 | 1,414 | 1,421 | ±0 | ±0% | 180,000 |
| 2010/12/29 | 1,407 | 1,425 | 1,407 | 1,421 | +4 | +0.3% | 122,000 |
| 2010/12/28 | 1,395 | 1,422 | 1,395 | 1,417 | +10 | +0.7% | 106,000 |
| 2010/12/27 | 1,402 | 1,415 | 1,394 | 1,407 | -7 | -0.5% | 163,000 |
| 2010/12/24 | 1,420 | 1,424 | 1,410 | 1,414 | -15 | -1% | 291,000 |
| 2010/12/22 | 1,435 | 1,440 | 1,426 | 1,429 | -6 | -0.4% | 190,000 |
| 2010/12/21 | 1,416 | 1,441 | 1,416 | 1,435 | +10 | +0.7% | 190,000 |
| 2010/12/20 | 1,436 | 1,436 | 1,415 | 1,425 | -14 | -1% | 193,000 |
| 2010/12/17 | 1,427 | 1,442 | 1,427 | 1,439 | +15 | +1.1% | 277,000 |
| 2010/12/16 | 1,407 | 1,432 | 1,407 | 1,424 | +3 | +0.2% | 278,000 |
| 2010/12/15 | 1,386 | 1,421 | 1,386 | 1,421 | +27 | +1.9% | 402,000 |
| 2010/12/14 | 1,386 | 1,402 | 1,385 | 1,394 | +8 | +0.6% | 190,000 |
| 2010/12/13 | 1,369 | 1,388 | 1,362 | 1,386 | +13 | +0.9% | 251,000 |
| 2010/12/10 | 1,369 | 1,381 | 1,362 | 1,373 | -6 | -0.4% | 309,000 |
| 2010/12/09 | 1,384 | 1,388 | 1,370 | 1,379 | +10 | +0.7% | 359,000 |
| 2010/12/08 | 1,372 | 1,396 | 1,357 | 1,369 | -37 | -2.6% | 649,000 |
| 2010/12/07 | 1,382 | 1,426 | 1,377 | 1,406 | +5 | +0.4% | 445,000 |
| 2010/12/06 | 1,400 | 1,432 | 1,394 | 1,401 | -9 | -0.6% | 552,000 |
| 2010/12/03 | 1,380 | 1,453 | 1,377 | 1,410 | +60 | +4.4% | 2,119,000 |
| 2010/12/02 | 1,365 | 1,373 | 1,345 | 1,350 | -8 | -0.6% | 322,000 |
| 2010/12/01 | 1,345 | 1,369 | 1,337 | 1,358 | +23 | +1.7% | 562,000 |
| 2010/11/30 | 1,340 | 1,350 | 1,331 | 1,335 | +3 | +0.2% | 383,000 |
| 2010/11/29 | 1,313 | 1,338 | 1,313 | 1,332 | +12 | +0.9% | 189,000 |
| 2010/11/26 | 1,318 | 1,330 | 1,315 | 1,320 | -5 | -0.4% | 306,000 |
| 2010/11/25 | 1,345 | 1,345 | 1,317 | 1,325 | -2 | -0.2% | 340,000 |
| 2010/11/24 | 1,320 | 1,335 | 1,318 | 1,327 | -2 | -0.2% | 251,000 |
| 2010/11/22 | 1,328 | 1,333 | 1,315 | 1,329 | +10 | +0.8% | 248,000 |
| 2010/11/19 | 1,318 | 1,326 | 1,299 | 1,319 | -4 | -0.3% | 253,000 |
| 2010/11/18 | 1,300 | 1,323 | 1,296 | 1,323 | +15 | +1.1% | 323,000 |
| 2010/11/17 | 1,296 | 1,310 | 1,296 | 1,308 | -1 | -0.1% | 100,000 |
| 2010/11/16 | 1,310 | 1,313 | 1,304 | 1,309 | -5 | -0.4% | 104,000 |
| 2010/11/15 | 1,322 | 1,322 | 1,292 | 1,314 | +8 | +0.6% | 186,000 |
| 2010/11/12 | 1,303 | 1,325 | 1,300 | 1,306 | +10 | +0.8% | 314,000 |
| 2010/11/11 | 1,313 | 1,316 | 1,292 | 1,296 | -28 | -2.1% | 485,000 |
| 2010/11/10 | 1,379 | 1,381 | 1,308 | 1,324 | -55 | -4% | 800,000 |
| 2010/11/09 | 1,312 | 1,405 | 1,307 | 1,379 | +65 | +4.9% | 775,000 |
| 2010/11/08 | 1,294 | 1,314 | 1,292 | 1,314 | +5 | +0.4% | 235,000 |
| 2010/11/05 | 1,303 | 1,323 | 1,302 | 1,309 | +3 | +0.2% | 205,000 |
| 2010/11/04 | 1,267 | 1,319 | 1,267 | 1,306 | +45 | +3.6% | 351,000 |
| 2010/11/02 | 1,259 | 1,275 | 1,244 | 1,261 | +10 | +0.8% | 229,000 |
| 2010/11/01 | 1,244 | 1,258 | 1,242 | 1,251 | -5 | -0.4% | 112,000 |
| 2010/10/29 | 1,248 | 1,267 | 1,246 | 1,256 | -4 | -0.3% | 173,000 |
| 2010/10/28 | 1,253 | 1,263 | 1,244 | 1,260 | +7 | +0.6% | 244,000 |
| 2010/10/27 | 1,271 | 1,271 | 1,253 | 1,253 | -13 | -1% | 130,000 |
| 2010/10/26 | 1,280 | 1,280 | 1,264 | 1,266 | -5 | -0.4% | 126,000 |
| 2010/10/25 | 1,294 | 1,297 | 1,259 | 1,271 | -12 | -0.9% | 144,000 |
| 2010/10/22 | 1,279 | 1,284 | 1,268 | 1,283 | +1 | +0.1% | 101,000 |
| 2010/10/21 | 1,286 | 1,288 | 1,273 | 1,282 | -4 | -0.3% | 102,000 |
| 2010/10/20 | 1,304 | 1,304 | 1,266 | 1,286 | -2 | -0.2% | 208,000 |
| 2010/10/19 | 1,279 | 1,290 | 1,274 | 1,288 | +24 | +1.9% | 190,000 |
3401～
3450
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 210,100円 | +0.4% | -8.4% | 2.52% | 27.77倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
